OpenVSafe by OpenVAERS
Search V-safe

R22-15210-89635

3 vaccinations 4 coded responses 24 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
660 / KS
Registered
2021-03-30
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-30
    Registered in v-safe
  3. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Headache, Abdominal pain
    Adult check-in
  6. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-19
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Swollen node in armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Swollen lymph node in armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-28
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  18. 2021-05-03
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-05-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-26
    Survey response — day 35, dose 2
    MedDRA: Anxiety, Stress — Feeling: Good · Be unable to do your normal daily activities
    Free text: Anxiety and stress
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-04
    Dose 3 — Pfizer-BioNTech
  26. 2022-04-19
    Health check-in — 12 months, dose 2
    Feeling: Poor
    Adult check-in
  27. 2022-05-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-11-04
    Survey response — 12 months, dose 3
    MedDRA: Bronchitis, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Covid and bronchitis
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-11-04
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2022-11-07

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech
22021-04-19Pfizer-BioNTech
32021-11-04Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-21

Systemic reaction (other): Swollen node in armpit

2021-04-24

Systemic reaction (other): Swollen lymph node in armpit

Release 8 — day 35, dose 2

2021-05-26

Symptoms: Anxiety and stress

Release 12 — 12 months, dose 3

2022-11-04

Symptoms: Covid and bronchitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDBronchitis · · ✓
SDCOVID-19 · · ✓
SDStress ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release